A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy approved for a Phase I clinical trial. It's a historical milestone that could reverse what has, until now, been an incurable injury. Source of Article
High blood sugars have long been known to cause eye damage in diabetics. However, new research has found that low blood sugar may also contribute. The good news is that it also identified a way of preventing or treating the damage. Source of Article
A compound derived from a Himalayan fungus has been refined by scientists for a chemotherapy drug with powerful anti-cancer effects. NUC-7738 is yielding encouraging results in ongoing Phase 2 clinical trials, and is advancing towards approval. Source of Article
It's never a good thing when harmful bacteria are present on surfaces in hospitals, as they can cause life-threatening infections in patients. A new paint could help keep that from happening, by quickly killing any microbes that land on it. Source of Article
A three-year study has found robust evidence that one vaccine for respiratory syncytial virus offers older adults long-term protection, even if efficacy wanes. Despite this, just one dose cut serious illness by nearly two thirds across three seasons. Source of Article
Tiny 3D organs connected themselves in a lab dish, forming a replica of the human pain pathway, in a new study. The discovery allows scientists to better understand chronic pain and offers an animal-free method of testing pain treatments. Source of Article
A decade-long study of 35 million Americans in 10 states has found that group A streptococcus infections have more than doubled. What's more, "strep" – which can cause a bizarre flesh-eating disease – has become increasingly resistant to antibiotics. Source of Article
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on shelves by early next year. Source of Article
COVID antiviral Paxlovid wasn't perfect. Many patients couldn't take it due to extreme side effects but now the second generation of antivirals are on the way and they promise better efficacy and fewer drug complications. Source of Article
A mainstay of Parkinson's disease treatment, levodopa can cause nasty side-effects with long-term use. A recent human trial found that a new drug significantly reduces these effects, representing a breakthrough milestone in Parkinson’s treatment. Source of Article
Copyright © 2025 Nasni Consultants Ltd. All Rights Reserved